Top Markets
#1 Fabric Protocol Fabric Protocol +38.98%
#2 GALA GALA +37.33%
#3 Magma Finance Magma Finance +35.47%
#4 COTI COTI +31.99%
#5 Wrapped STX (Velar) Wrapped STX (Velar) +30.56%
#6 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +29.58%
#7 Tutorial Tutorial +28.70%
#8 Bitcoin Cash Bitcoin Cash +28.42%
#9 Binance-Peg ZEC Binance-Peg ZEC +26.27%
#10 OmniBridge Bridged Zcash (Solana) OmniBridge Bridged Zcash (Solana) +26.13%
Coin of the day
Fabric Protocol Fabric Protocol
設定
言語
日本
通貨
USD
テーマ
ERYTECH Pharma S.A. ERYTECH Pharma S.A.

ERYTECH Pharma S.A.

ERYP
株式のランク #24694
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on... ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on creating innovative therapies derived from red blood cells. These treatments target various types of cancer and rare (orphan) diseases, with the company operating in both France and the United States. Its primary experimental drug, eryaspase, is currently undergoing Phase 3 clinical trials for patients battling second-line pancreatic cancer. Furthermore, this candidate is also in Phase 2 development for triple-negative breast cancer and for individuals with second-line acute lymphoblastic leukemia. The company is additionally advancing erymethionase, a preclinical-stage product. This candidate utilizes methionine-gamma-lyase, encased within red blood cells, to specifically address cancers that are dependent on methionine for growth. Established in 2004, ERYTECH Pharma's corporate headquarters are situated in Lyon, France.
株価
$0.95011029
最終同期: 2023-06-28
時価総額
$57.72M
変化（1日）
8.53%
変化（1年）
0.00%
国
FR
取引 ERYTECH Pharma S.A. (ERYP)

カテゴリー

Healthcare
ERYTECH Pharma S.A.（ERYP）の収益
Aug 2026 時点の収益 TTM: 0
ERYTECH Pharma S.A. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
ERYTECH Pharma S.A. の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH